CollaGenex Pharmaceuticals Report issue

For profit Phase 4
Founded: Newtown PA United States (1992)
Status: Acquired by Galderma (2008) → now Nestle (2014)

Organization Overview

First Clinical Trial
2002
NCT00041977
First Marketed Drug
1998
doxycycline (vibramycin)
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

COLLAGENEX

Active Ingredients

Marketed Drugs (1)

doxycycline (vibramycin) (1998)

Drugs in Phase 4 Trials (1)

doxycycline (vibramycin) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Rosacea (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 1